Your browser doesn't support javascript.
loading
Recombinant human GLP-1 beinaglutide regulates lipid metabolism of adipose tissues in diet-induced obese mice.
Zhang, Feng; Chen, Zhinan; Wu, Dan; Tian, Le; Chen, Qing; Ye, Yuqing; Chen, Wei; Wu, Xiaoxing; Wu, Peng; Yuan, Weilan; Qiu, Yan; Zhou, Zhiguang; Du, Zhiqiang; Hu, Fang.
Afiliação
  • Zhang F; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Chen Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Wu D; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Tian L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Chen Q; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Ye Y; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Chen W; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Wu X; Innovation Center, Shanghai Benemae Pharmaceutical Corporation, 916 Ziping Road, PuDong, Shanghai, China.
  • Wu P; Innovation Center, Shanghai Benemae Pharmaceutical Corporation, 916 Ziping Road, PuDong, Shanghai, China.
  • Yuan W; Innovation Center, Shanghai Benemae Pharmaceutical Corporation, 916 Ziping Road, PuDong, Shanghai, China.
  • Qiu Y; Innovation Center, Shanghai Benemae Pharmaceutical Corporation, 916 Ziping Road, PuDong, Shanghai, China.
  • Zhou Z; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
  • Du Z; Innovation Center, Shanghai Benemae Pharmaceutical Corporation, 916 Ziping Road, PuDong, Shanghai, China.
  • Hu F; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education,Metabolic Syndrome Research Center, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011 Hunan, China.
iScience ; 24(12): 103382, 2021 Dec 17.
Article em En | MEDLINE | ID: mdl-34841227

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China